- Signa Vitae - http://www.signavitae.com -

Minimally Invasive Surfactant Therapy – A Single Center Experience

Surfactant replacement therapy is the mainstay treatment for preterm infants with respiratory distress syndrome. In recent years, the growing interest in non-invasive ventilation has led to a variety of novel approaches of surfactant administration (intra-amniotic instillation, pharyngeal instillation, administration via laryngeal mask airway, administration via thin endotracheal catheter without IPPV, aerosolized/nebulized surfactant administration in spontaneously breathing infants). In our Centre last year a number of preterm infants with RDS were treated using MIST technique, in which surfactant is administered using a thin feeding tube inserted below the vocal cords. In the paper we describe our experience with the novel technique and report short term outcomes.

Darjan Kardum, darjan_kardum@yahoo.com
Neonatal Intensive Care Unit, Department of Paediatrics,
University Hospital Osijek, J. Huttlera 4, 31000 Osijek, Croatia

Creative Commons LicenseThis work is licensed under a Creative Commons Attribution 4.0 International License